A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymp node density

International Braz J Urol

Volumn 32, Issue 5, 2006, Pages 536-547

  Cheng, Chi W ^a   Ng, Chi F ^a   Chan, Chi K ^a   Wong, Wai S ^a   Hui, Pun E ^a   Wong, Yim F ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bladder; Carcinoma; Cystectomy; Lymph nodes; Transitional cell

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CORRELATION ANALYSIS; CYSTECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; TRANSITIONAL CELL CARCINOMA; UNIVARIATE ANALYSIS;

EID: 33751265991     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/s1677-55382006000500006     Document Type: Review

References (21)

1. Frazier HA, Robertson JE, Dodge RK, Paulson DF: The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer. 1993; 71: 3993-4001.
2. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al.: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001; 19: 666-75.
3. Lerner SP, Skinner DG, Lieskovsky G, Boyd SD, Groshen SL, Ziogas A, et al.: The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol. 1993; 149: 758-64.
4. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF: Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 2002; 167: 1295-8.
5. Lieskovsky G, Skinner DG: Role of lymphadenectomy in the treatment of bladder cancer. Urol Clin North Am. 1984; 11: 709-16.
6. Ariyoshi A, Minoda K, Komatsu K, Fujisawa Y, Yamaguchi A, Yoshida T: Does 'extended' pelvic lymphadenectomy truly contribute to the management of bladder carcinoma? Eur Urol. 1986; 12: 314-7.
7. Herr HW: Bladder cancer: pelvic lymphadenectomy revisited. J Surg Oncol. 1988; 37: 242-5.
8. Wishnow KI, Johnson DE, Ro JY, Swanson DA, Babaian RJ, von Eschenbach AC: Incidence, extent and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer. J Urol. 1987; 137: 408-10.
9. Vieweg J, Whitmore WF Jr, Herr HW, Sogani PC, Russo P, Sheinfeld J, et al.: The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience. Cancer. 1994; 73: 3020-8.
10. Turner WH, Markwalder R, Perrig S, Studer UE: Meticulous pelvic lymphadenectomy in surgical treatment of the invasive bladder cancer: an option or a must? Eur Urol. 1998; 33: 21-2.
11. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK: Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int. 2000; 85: 817-23.
12. Brossner C, Pycha A, Toth A, Mian C, Kuber W: Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int. 2004; 93: 64-6.
13. Leissner J, Ghoneim MA, Abol-Enein H, Thuroff JW, Franzaring L, Fisch M, et al.: Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol. 2004; 171: 139-44.
14. Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP: Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol. 2004;171: 1830-4.
15. Sherif A, De La Torre M, Malmstrom PU, Thorn M: Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol. 2001; 166: 812-5.
16. Ghoneim MA, Abol-Enein H: Lymphadenectomy with cystectomy: is it necessary and what is its extent? Eur Urol. 2004; 46: 457-61.
17. Stein JP, Cai J, Groshen S, Skinner DG: Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003; 170:35-41.
18. Herr HW: Superiority of ratio based lymph node staging for bladder cancer. J Urol. 2003; 169: 943-5.
19. Konety BR, Joslyn SA, O'Donnell MA: Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol. 2003; 169: 946-50.
20. Raghavan D: Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder. Urol Oncol. 2003; 21: 468-74.
21. Shelley MD, Wilt TJ, Barber J, Mason MD: A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice? Clin Oncol (R Coll Radiol). 2004; 16: 166-71.